EUVIMEDEUVIMED entdecken
Open Access

Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathology

Bruna Bellaver, Albert Puig-Pijoan, João Pedro Ferrari-Souza, Douglas T Leffa, Firoza Z Lussier, Pamela C L Ferreira, Cécile Tissot, Guilherme Povala, Joseph Therriault, Andréa L Benedet, Nicholas J Ashton, Stijn Servaes und 21 weitere

Alzheimer's & Dementia · 2023-09 · 19 (9) · 3815-3825

DOI: 10.1002/alz.13014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 15.03.2023. Verfasst von Bruna Bellaver und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Amyloid‐β (Aβ) and tau can be quantified in blood. However, biological factors can influence the levels of brain‐derived proteins in the blood. The blood‐brain barrier (BBB) regulates protein transport between cerebrospinal fluid (CSF) and blood. BBB altered permeability might affect the relationship between brain and blood biomarkers. METHODS We assessed 224 participants in research (TRIAD, n = 96) and clinical (BIODEGMAR, n = 128) cohorts with plasma and CSF/positron emission tomography Aβ, p‐tau, and albumin measures. RESULTS Plasma Aβ 42/40 better identified CSF Aβ 42/40 and Aβ‐PET positivity in individuals with high BBB permeability. An interaction between plasma Aβ 42/40 and BBB permeability on CSF Aβ 42/40 was observed. Voxel‐wise models estimated that the association of positron emission tomography (PET), with plasma Aβ was most affected by BBB permeability in AD‐related brain regions. BBB permeability did not significantly impact the relationship between brain and plasma p‐tau levels. DISCUSSION These findings suggest that BBB integrity may influence the performance of plasma Aβ, but not p‐tau, biomarkers in research and clinical settings. HIGHLIGHTS BBB permeability affects the association between brain and plasma Aβ levels. BBB integrity does not affect the association between brain and plasma p‐tau levels. Plasma Aβ was most affected by BBB permeability in AD‐related brain regions. BBB permeability increases with age but not according to cognitive status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansBlood-Brain Barriertau ProteinsAmyloid beta-PeptidesBrainPositron-Emission TomographyBiomarkersPeptide Fragments

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid-βblood biomarkersblood-brain barrierconfounding factors

Substanzen

tau ProteinsAmyloid beta-PeptidesBiomarkersPeptide Fragments

Autor:innen und Institutionen

  • Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
  • Cognitive Decline and Movement Disorders Unit, Neurology Department, Hospital del Mar, Barcelona, Spain.
  • IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services socia…

ORCID-Profile: Marc Suárez-Calvet

Förderung

  • NIA NIH HHS

Zitieren

APA

Bellaver, B., Puig-Pijoan, A., Ferrari-Souza, J. P., Leffa, D. T., Lussier, F. Z., Ferreira, P. C. L., Tissot, C., Povala, G., Therriault, J., Benedet, A. L., Ashton, N. J., Servaes, S., Chamoun, M., Stevenson, J., Rahmouni, N., Vermeiren, M., Macedo, A. C., Fernández-Lebrero, A., García-Escobar, G., …, & Pascoal, T. A. (2023). Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathology. Alzheimer's & Dementia, 19(9), 3815-3825. https://doi.org/10.1002/alz.13014

Vancouver

Bellaver B, Puig-Pijoan A, Ferrari-Souza JP, Leffa DT, Lussier FZ, Ferreira PCL, et al. Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathology. Alzheimer's & Dementia. 2023;19(9):3815-3825. doi:10.1002/alz.13014

BibTeX
@article{Bellaver2023,
  author = {Bellaver, Bruna and Puig-Pijoan, Albert and Ferrari-Souza, João Pedro and Leffa, Douglas T and Lussier, Firoza Z and Ferreira, Pamela C L and Tissot, Cécile and Povala, Guilherme and Therriault, Joseph and Benedet, Andréa L and Ashton, Nicholas J and Servaes, Stijn and Chamoun, Mira and Stevenson, Jenna and Rahmouni, Nesrine and Vermeiren, Marie and Macedo, Arthur C and Fernández-Lebrero, Aida and García-Escobar, Greta and Navalpotro-Gómez, Irene and Lopez, Oscar and Tudorascu, Dana L and Cohen, Ann and Villemagne, Victor L and Klunk, William E and Gauthier, Serge and Zimmer, Eduardo R and Karikari, Thomas K and Blennow, Kaj and Zetterberg, Henrik and Suárez-Calvet, Marc and Rosa-Neto, Pedro and Pascoal, Tharick A},
  title = {Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathology},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {9},
  pages = {3815--3825},
  doi = {10.1002/alz.13014}
}
Kostenlos starten →